Sale of 400 shares at $26.6375 per share.
Reporting Person Ring Christine · Officer Title Chief Legal Officer · Transaction Code S
Traded Sep 2, 2026 · Disclosed Sep 2, 2026
Source: SEC Form 4 · 0001817199-26-000030 · filed 2026-09-02 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Nurix Therapeutics, Inc. (NRIX)." Disclosed 2026-09-02. https://desqlong.com/cards/0001817199-26-000030-3 (retrieved 2026-09-26).